Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Increased collagen content in insulin-resistant skeletal muscle.

Berria R, Wang L, Richardson DK, Finlayson J, Belfort R, Pratipanawatr T, De Filippis EA, Kashyap S, Mandarino LJ.

Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E560-5. Epub 2005 Oct 25.

3.
4.

Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.

Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ.

Diabetes. 2004 Jan;53(1):25-31.

6.

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

Kelley DE, He J, Menshikova EV, Ritov VB.

Diabetes. 2002 Oct;51(10):2944-50.

7.

The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.

Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredrickson A, Beattie J, Thériault R.

J Clin Invest. 1996 Jun 15;97(12):2705-13.

8.

Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.

Mandarino LJ, Consoli A, Jain A, Kelley DE.

Am J Physiol. 1996 Mar;270(3 Pt 1):E463-70.

PMID:
8638694
9.
10.

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ.

J Clin Invest. 1997 Jul 15;100(2):449-58.

11.

GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance?

Gaster M, Ottosen PD, Vach W, Christiansen H, Staehr P, Beck-Nielsen H, Schrøder HD.

APMIS. 2003 Feb;111(2):338-48.

PMID:
12716391
12.

Effect of a 2-day very low-energy diet on skeletal muscle insulin sensitivity in obese type 2 diabetic patients on insulin therapy.

Jazet IM, Ouwens DM, Schaart G, Pijl H, Keizer H, Maassen JA, Meinders AE.

Metabolism. 2005 Dec;54(12):1669-78.

PMID:
16311102
13.

Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.

Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL.

Diabetes. 2000 Aug;49(8):1353-8.

PMID:
10923637
15.

Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P.

Diabetologia. 2007 Jan;50(1):113-20. Epub 2006 Nov 9.

PMID:
17093944
17.

Insulin signaling and glucose transport in insulin resistant human skeletal muscle.

Karlsson HK, Zierath JR.

Cell Biochem Biophys. 2007;48(2-3):103-13. Review.

PMID:
17709880
18.

Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport.

Youngren JF, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID.

Diabetes. 1996 Oct;45(10):1324-8.

PMID:
8826966
19.

Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes.

O'Gorman DJ, Karlsson HK, McQuaid S, Yousif O, Rahman Y, Gasparro D, Glund S, Chibalin AV, Zierath JR, Nolan JJ.

Diabetologia. 2006 Dec;49(12):2983-92. Epub 2006 Sep 26.

PMID:
17019595
20.

The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes.

Giebelstein J, Poschmann G, Højlund K, Schechinger W, Dietrich JW, Levin K, Beck-Nielsen H, Podwojski K, Stühler K, Meyer HE, Klein HH.

Diabetologia. 2012 Apr;55(4):1114-27. doi: 10.1007/s00125-012-2456-x. Epub 2012 Jan 27. Erratum in: Diabetologia. 2012 Jul;55(7):2083.

PMID:
22282162

Supplemental Content

Support Center